DVA News and Press, DaVita Inc. From 10/11/23

2023-10-11 12:51:59 ET Shares of several major dialysis stocks plunged on Wednesday after Novo Nordisk (NYSE: NVO) indicated one of its diabetes treatments could also be used to treat chronic kidney disease. Dialysis products and services providers were broadly negative in early...

2023-10-11 11:15:44 ET More on Eli Lilly, Novo Nordisk, etc. Eli Lilly: Do Not Chase This Stock Over The Cliff Eli Lilly: Big Cancer Bet With Point Biopharma Global Purchase Eli Lilly POINTs Toward Radiopharmaceutical Ambitions Biggest stock movers today: Pio...

2023-10-11 10:03:52 ET More on DaVita DaVita: Continued Economic Hurdles, Market Expectations May Be Correct DaVita Inc. (DVA) Q2 2023 Earnings Call Transcript DaVita: Breakout Not Supported Without Leverage Effects, Reiterate Hold Dialysis stocks tumble in w...

2023-10-11 09:37:37 ET Stock markets looked poised to continue their winning ways on Wednesday morning, as stock index futures were higher across the board. Investors will get a look today at the latest thought process from the Federal Reserve when it releases the minutes of its most recent...

2023-10-11 09:24:05 ET More on Baxter, DaVita, etc. Outset Medical Faces Regulatory Delays Amid Heavy Cash Burn (Rating Downgrade) DaVita: Continued Economic Hurdles, Market Expectations May Be Correct Dividend Challengers Review: Baxter International DaVita ...

2023-10-11 08:28:56 ET More on Baxter, Denison Mines, etc. Denison Mines: Top Projects, Robust Balance Sheet, And Deeply Undervalued Denison Mines: A Promising Uranium Exploration Company Denison Mines: The Feasibility Study Demonstrates Wheeler's Potential D...

2023-10-11 06:53:54 ET Summary Birkenstock prices IPO at $46 per share, raising close to $1.5B and valuing the company at just under $9B. The Biden administration is set to announce up to $7B in funds for hydrogen hubs in the US. Samsung Electronics expects a decline in Q3 ope...

2023-10-11 05:57:33 ET Related stories E2open Parent Holdings, Inc. (ETWO) Q2 2024 Earnings Call Transcript E2open Parent Holdings: Still Running House Money But Q2 Was Rough DaVita: Continued Economic Hurdles, Market Expectations May Be Correct Novo Nordisk ...

2023-10-10 18:07:12 ET More on DaVita DaVita: Continued Economic Hurdles, Market Expectations May Be Correct DaVita Inc. (DVA) Q2 2023 Earnings Call Transcript DaVita: Breakout Not Supported Without Leverage Effects, Reiterate Hold DaVita raised to Buy at UBS...

2023-10-04 21:46:29 ET Summary DaVita Inc. stock has been heavily sold in '23, trading below its 50-day moving average for the past 8 weeks. The company lacks economic value, and its reinvestment runway looks limited, producing sub-standard returns on capital. The market expec...